Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.

Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.

BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Walker, A, Mulenga, V, Sinyinza, F, Lishimpi, K, Nunn, A, Chintu, C, Gibb, D
Formato:	Journal article
Idioma:	English
Publicado em:	2006

Registos relacionados

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Por: Chintu, C, et al.
Publicado em: (2004)

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Por: Walker, A, et al.
Publicado em: (2007)

Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
Por: Walker, A, et al.
Publicado em: (2009)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
Por: Haberer, J, et al.
Publicado em: (2011)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
Por: Jessica E Haberer, et al.
Publicado em: (2011-04-01)

Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
Por: Mulenga, V, et al.
Publicado em: (2007)

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.
Por: Gupta, R, et al.
Publicado em: (2010)

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Por: Prendergast, A, et al.
Publicado em: (2011)

Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy.
Por: Freeman W Chabala, et al.
Publicado em: (2021-01-01)

The Commodified Aestheticization of the Chap
Por: Jørgen Riber Christensen
Publicado em: (2019-12-01)

Monitoring of highly active antiretroviral therapy in HIV infection.
Por: Walker, A, et al.
Publicado em: (2011)

Dynamics of accumulation of drug resistance mutations in the absence of virological monitoring in HIV-1-infected Zambian children using adult Triomune (fixed-dose combination d4T, 3TC and NVP)
Por: Gupta, R, et al.
Publicado em: (2009)

Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
Por: Gibb, D, et al.
Publicado em: (2005)

Dynamics of emergence and linkage of HIV reverse transcriptase Q151M MDR complex in children within first-line antiretroviral rollout uncovered by single-genome sequencing
Por: Mbisa, J, et al.
Publicado em: (2009)

Pharmacokinetics of antiretroviral drugs in infancy
Por: Helen McIlleron, et al.
Publicado em: (2009-12-01)

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
Por: Ellis, J, et al.
Publicado em: (2007)

DATA SHARING EFFICIENCY ON THE ZAMBIAN RESIDENTIAL PROPERTY MARKET: CASE STUDY OF LUSAKA
Por: Christopher Mulenga
Publicado em: (2019-09-01)

Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era
Por: Mathura Ravishankar, et al.
Publicado em: (2022-06-01)

CHAP: Cotton-Harvesting Autonomous Platform
Por: Joe Mari Maja, et al.
Publicado em: (2021-04-01)

Increasing Proportion of HIV-Infected Pregnant Zambian Women Attending Antenatal Care Are Already on Antiretroviral Therapy (2010–2015)
Por: Sehlulekile Gumede-Moyo, et al.
Publicado em: (2019-06-01)

Understanding the Seriousness of ‘Self’ Identity and Changing Process of HIV among Zambian School Teachers Living with Antiretroviral Therapy (ART)
Por: Sanny Mulubale
Publicado em: (2020-12-01)

T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy.
Por: Caroline C Chisenga, et al.
Publicado em: (2015-01-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Por: Gibb, D, et al.
Publicado em: (2002)

Neopterin and other indicators of HIV progression in Zambian adults
Por: Hosp, M, et al.
Publicado em: (2000)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
Por: Lewis, J, et al.
Publicado em: (2017)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
Por: De Rossi, A, et al.
Publicado em: (2002)

Epithelial Abnormalities in the Small Intestine of Zambian Children With Stunting
Por: Chola Mulenga, et al.
Publicado em: (2022-03-01)

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
Por: Fillekes, Q, et al.
Publicado em: (2013)

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
Por: Oudijk, J, et al.
Publicado em: (2012)

Methods for measuring body composition in Zambian adolescents living with HIV.
Por: Suzanne Filteau, et al.
Publicado em: (2024-01-01)

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
Por: Walker, A, et al.
Publicado em: (2004)

An evaluation of low-cost progression markers in HIV-1 seropositive Zambians.
Por: Hosp, M, et al.
Publicado em: (2000)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
Por: Phillips, A, et al.
Publicado em: (2004)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Por: Musiime, V, et al.
Publicado em: (2014)

Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
Por: Mulenga, V, et al.
Publicado em: (2010)

When should children with HIV infection be started on antiretroviral therapy?
Por: Steven B Welch, et al.
Publicado em: (2008-03-01)

Challenging the myth of women's empowerment: Mining development and commercial sex in a Zambian town
Por: Lesley Johnston, et al.
Publicado em: (2024-01-01)

HIV progression and predictors of mortality in a community-based cohort of Zambian adults.
Por: Kitchen, M, et al.
Publicado em: (2008)

Evaluating layered stigma from comorbid HIV and epilepsy among Zambian adults
Por: Melissa A. Elafros, et al.
Publicado em: (2018-12-01)

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
Por: De Rossi, A, et al.
Publicado em: (2005)